Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lisi S.A. (FII.PA)
Belfort, FR
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.87% | +2.58% | +8.84% | +20.89% | +38.02% | +27.50% | +107.35% | +173.54% | +133.05% | +170.80% | +10,089,418,677.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 2 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Aerospace & Defense: +15.4%-2.6% Q4'25: -4.9% (vs Q4'23)
-
EPS growth Aerospace & Defense: +32.2%+150.8% ★ Q4'25: +319.2% (vs Q4'23)
-
FCF margin FCF growth · Aerospace & Defense: +45.0%-0.3% Q4'25: +9.3% (vs Q4'23)
-
EBIT margin Aerospace & Defense: +9.2%+9.2% Q4'25: +8.5% (vs Q4'23)
-
ROIC Aerospace & Defense: +6.2%+8.8% ★ Q4'25: +13.6% (vs Q4'23)
-
Share dilution Aerospace & Defense: +0.0%-0.5% ★ Q4'25: +0.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Aerospace & Defense: 0.16×1.99× Q4'25: 1.19× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
572.91M
est.
|
523.16M
est: 525.41M (-0.4%)
|
514.67M
est: 510.14M (+0.9%)
|
540.97M
est: 547.86M (-1.3%)
|
631.21M
est: 626.37M (+0.8%)
|
759.55M
est: 745.69M (+1.9%)
|
836.68M
est: 827.33M (+1.1%)
|
844.25M
est: 856.42M (-1.4%)
|
676.07M
est: 705.28M (-4.1%)
|
795.78M
est: 764.63M (+4.1%)
|
925.10M
est: 914.42M (+1.2%)
|
1.10B
est: 1.08B (+1.9%)
|
1.16B
est: 1.17B (-0.3%)
|
1.32B
est: 1.30B (+2.1%)
|
1.47B
est: 1.46B (+1.0%)
|
1.59B
est: 1.55B (+2.7%)
|
1.67B
est: 1.64B (+1.9%)
|
1.68B
est: 1.65B (+2.0%)
|
1.73B
est: 1.71B (+1.0%)
|
1.23B
est: 1.32B (-6.5%)
|
1.16B
est: 1.17B (-0.8%)
|
1.43B
est: 1.42B (+0.3%)
|
1.63B
est: 1.77B (-7.8%)
|
1.79B
est: 1.78B (+1.1%)
|
1.75B
est: 1.87B (-6.5%)
|
1.93B
1.91B – 1.95B
+3.2% YoY
|
2.10B
2.04B – 2.15B
+9.0% YoY
|
2.27B
2.27B – 2.28B
+8.1% YoY
|
2.36B
2.32B – 2.41B
+4.0% YoY
|
2.48B
2.43B – 2.53B
+5.0% YoY
|
| EBITDA |
44.84M
est.
|
73.72M
est: 28.98M (+154.4%)
|
78.29M
est: 50.88M (+53.9%)
|
78.93M
est: 69.81M (+13.1%)
|
90.55M
est: 88.15M (+2.7%)
|
122.52M
est: 91.94M (+33.3%)
|
144.96M
est: 74.22M (+95.3%)
|
139.23M
est: 136.75M (+1.8%)
|
64.71M
est: 102.20M (-36.7%)
|
95.91M
est: 78.92M (+21.5%)
|
135.34M
est: 108.95M (+24.2%)
|
152.10M
est: 150.80M (+0.9%)
|
175.27M
est: 159.16M (+10.1%)
|
196.43M
est: 187.98M (+4.5%)
|
220.28M
est: 213.05M (+3.4%)
|
238.33M
est: 191.59M (+24.4%)
|
242.76M
est: 270.19M (-10.2%)
|
234.58M
est: 204.79M (+14.5%)
|
274.29M
est: 197.79M (+38.7%)
|
78.54M
est: 167.72M (-53.2%)
|
161.25M
est: 183.96M (-12.3%)
|
182.95M
est: 193.69M (-5.5%)
|
182.04M
est: 273.84M (-33.5%)
|
241.33M
est: 276.73M (-12.8%)
|
253.91M
est: 289.61M (-12.3%)
|
298.79M
295.19M – 302.66M
+3.2% YoY
|
325.81M
316.61M – 333.67M
+9.0% YoY
|
352.26M
351.01M – 353.50M
+8.1% YoY
|
366.35M
358.84M – 373.23M
+4.0% YoY
|
384.84M
376.94M – 392.06M
+5.0% YoY
|
| EBIT |
60.10M
est.
|
47.04M
est: 46.77M (+0.6%)
|
51.86M
est: 28.45M (+82.3%)
|
51.42M
est: 44.03M (+16.8%)
|
59.58M
est: 50.53M (+17.9%)
|
86.05M
est: 70.98M (+21.2%)
|
106.54M
est: 95.19M (+11.9%)
|
100.60M
est: 109.21M (-7.9%)
|
21.14M
est: 77.33M (-72.7%)
|
61.96M
est: 23.93M (+158.9%)
|
87.62M
est: 57.88M (+51.4%)
|
92.66M
est: 99.51M (-6.9%)
|
114.58M
est: 98.68M (+16.1%)
|
131.80M
est: 127.95M (+3.0%)
|
131.81M
est: 147.15M (-10.4%)
|
157.46M
est: 149.78M (+5.1%)
|
153.74M
est: 155.81M (-1.3%)
|
136.52M
est: 169.92M (-19.7%)
|
155.11M
est: 128.97M (+20.3%)
|
41.51M
est: 87.04M (-52.3%)
|
66.93M
est: 95.47M (-29.9%)
|
83.99M
est: 100.52M (-16.4%)
|
81.14M
est: 234.06M (-65.3%)
|
131.56M
est: 236.54M (-44.4%)
|
161.01M
est: 247.55M (-35.0%)
|
255.40M
252.32M – 258.70M
+3.2% YoY
|
278.49M
270.62M – 285.21M
+9.0% YoY
|
301.09M
300.03M – 302.16M
+8.1% YoY
|
313.14M
306.72M – 319.03M
+4.0% YoY
|
328.94M
322.19M – 335.12M
+5.0% YoY
|
| Net Income |
33.71M
est.
|
12.38M
est: 23.94M (-48.3%)
|
21.00M
est: 12.04M (+74.4%)
|
31.40M
est: 22.55M (+39.2%)
|
35.57M
est: 27.90M (+27.5%)
|
47.99M
est: 42.40M (+13.2%)
|
67.55M
est: 53.25M (+26.8%)
|
56.23M
est: 69.98M (-19.6%)
|
9.42M
est: 46.28M (-79.6%)
|
32.92M
est: 10.13M (+224.9%)
|
59.18M
est: 39.34M (+50.4%)
|
57.29M
est: 68.62M (-16.5%)
|
74.64M
est: 62.00M (+20.4%)
|
81.46M
est: 82.93M (-1.8%)
|
81.76M
est: 92.92M (-12.0%)
|
107.01M
est: 87.07M (+22.9%)
|
107.97M
est: 113.05M (-4.5%)
|
92.07M
est: 109.38M (-15.8%)
|
69.77M
est: 94.77M (-26.4%)
|
-37.32M
est: 55.07M (-167.8%)
|
44.05M
est: 60.41M (-27.1%)
|
56.96M
est: 37.03M (+53.8%)
|
37.53M
est: 55.65M (-32.6%)
|
56.01M
est: 60.84M (-8.0%)
|
139.72M
est: 90.04M (+55.2%)
|
124.07M
109.09M – 144.51M
+37.8% YoY
|
154.55M
149.02M – 179.38M
+24.6% YoY
|
174.03M
160.63M – 191.17M
+12.6% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| SGA |
333.04M
est.
|
—
est: 310.43M (-100.0%)
|
—
est: 305.95M (-100.0%)
|
204.70M
est: 335.60M (-39.0%)
|
235.06M
est: 368.60M (-36.2%)
|
270.23M
est: 429.93M (-37.1%)
|
289.79M
est: 469.31M (-38.3%)
|
157.47M
est: 468.52M (-66.4%)
|
127.82M
est: 393.89M (-67.5%)
|
—
est: 449.35M (-100.0%)
|
80.86M
est: 581.08M (-86.1%)
|
81.26M
est: 669.00M (-87.9%)
|
300.0K
est: 704.06M (-100.0%)
|
513.27M
est: 762.27M (-32.7%)
|
569.24M
est: 898.49M (-36.6%)
|
604.48M
est: 946.96M (-36.2%)
|
619.33M
est: 994.96M (-37.8%)
|
640.05M
est: 982.59M (-34.9%)
|
90.42M
est: 1.03B (-91.3%)
|
-289.41M
est: 793.12M (-136.5%)
|
-168.14M
est: 869.91M (-119.3%)
|
-201.00M
est: 915.93M (-121.9%)
|
—
est: -100.92M (+100.0%)
|
—
est: -101.99M (+100.0%)
|
—
est: -106.74M (+100.0%)
|
-110.12M
-111.55M – -108.79M
-3.2% YoY
|
-120.08M
-122.97M – -116.69M
-9.0% YoY
|
-129.82M
-130.28M – -129.37M
-8.1% YoY
|
-135.02M
-137.56M – -132.25M
-4.0% YoY
|
-141.83M
-144.50M – -138.92M
-5.0% YoY
|
| EPS |
0.62
est.
|
0.26
est: 0.32 (-18.0%)
|
0.42
est: 0.49 (-15.0%)
|
0.66
est: 0.72 (-8.5%)
|
0.74
est: 0.70 (+5.7%)
|
0.99
est: 0.92 (+7.5%)
|
1.32
est: 1.21 (+9.3%)
|
1.08
est: 1.06 (+1.9%)
|
0.18
est: 0.30 (-39.4%)
|
0.64
est: 0.50 (+28.2%)
|
1.14
est: 1.03 (+10.7%)
|
1.09
est: 1.15 (-5.6%)
|
1.42
est: 1.49 (-5.0%)
|
1,550.00
est: 1.53 (+101,244.9%)
|
1.55
est: 1.65 (-6.3%)
|
2.00
est: 1.91 (+4.8%)
|
2.02
est: 2.11 (-4.2%)
|
1.73
est: 1.86 (-6.9%)
|
1.31
est: 1.78 (-26.3%)
|
-0.70
est: 0.33 (-315.2%)
|
0.83
est: 0.81 (+3.1%)
|
1.08
est: 1.16 (-6.6%)
|
0.83
est: 1.22 (-32.1%)
|
1.23
est: 1.31 (-6.3%)
|
3.06
est: 1.95 (+56.6%)
|
2.71
2.35 – 3.11
+38.7% YoY
|
3.37
3.21 – 3.86
+24.2% YoY
|
3.87
3.46 – 4.12
+14.9% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.27% | 1.98M | 0.33% |
| 2 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.26% | 2.69M | 0.58% |
| 3 | Select STOXX Europe Aerospace & Defense ETF EUAD | 0.16% | 1.53M | 0.50% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.11% | 1.13M | 0.58% |
| 5 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.11% | 465.7K | 0.48% |
| 6 | iShares MSCI Europe Small-Cap ETF IEUS | 0.10% | 178.2K | 0.41% |
| 7 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.10% | 3.45M | 0.30% |
| 8 | Avantis International Small Cap Equity ETF AVDS | 0.07% | 230.0K | 0.30% |
| 9 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.06% | 461.2K | 0.30% |
| 10 | Schwab International Small-Cap Equity ETF SCHC | 0.06% | 3.05M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Emmanuel Viellard | CEO, Member of Executive Board & Director | 839.9K | male |
| Anne-Delphine Beaulieu | Chief Transformation & AI Officer and Member of Executive Board | — | female |
| Cecile Le Corre | General Counsel, Secretary of the Board of Directors & Member of Executive Board | — | female |
| Christian Darville | Senior VP of Administration & Strategic development for North America and Member of Executive Board | — | male |
| Christophe Martin | Chief Industrial & Procurement Officer and Member of Executive Board | — | male |
| Emmanuel Neildez | CEO of LISI AEROSPACE & Member of Executive Board | — | male |
| Francois Liotard | Chief Executive Officer of Lisi Automotive | — | male |
| Francois-Xavier Du Cleuziou | Senior Vice President of Strategy & Procurement - Lisi Aerospace | — | male |
| Geoffroy Kohler | Chief CSR, Risks & Compliance Officer and Representative Director | — | male |
| Lionel Rivet | CEO of LISI MEDICAL & Member of Executive Board | — | male |
| Martin Beley | SVP & GM of Business Group Safety Mechanical Components - Lisi Automotive | — | male |
| Pierre-Emmanuel Kohler | VP of Information & Technology and Member of Executive Board | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FII.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
